Close
CDMO Safety Testing 2026
Novotech

Hungary Becomes First EU Country To Use Russian Vaccine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Hungary on Friday began innoculating its population with the Russian-made Sputnik V coronavirus vaccine. The vaccinations began in four hospitals in the country’s capital Budapest, according to Chief Medical Officer, Cecilia Muller.

Speaking during a news conference, Muller said around 2,800 doses of the Russian vaccine were expected to be administered on Friday.

Hungary also expects to receive 500,000 doses of the Chinese Sinopharm COVID-19 vaccine next week, along with 200,000 doses of the Russian Sputnik V vaccine to arrive later this month.

The country has purchased enough Sputnik V doses to treat 1 million people and enough Sinopharm doses to treat 2.5 million, officials said.

The country’s government has been critical of the European Union’s sluggish vaccine rollout, and in recent months has sought vaccines from countries outside the bloc’s common procurement program.

Hungary’s Prime Minister Viktor Orban has rejected arguments that only vaccines approved by the European Medicines Agency, the EU’s medicines regulator, should be approved for use in Hungary.

He has also claimed the increasing proportion of Hungarians receiving COVID-19 vaccinations should be enough to prevent the need for new pandemic restrictions in Hungary, despite recent increases in infections and deaths.

A nighttime curfew of 8 p.m. to 5 a.m., limitation of restaurants to take-out and delivery service and mandatory shop closures at 7 p.m. have been in place in the country since November 11 and will remain in force until at least March 1.

As of Friday, 13,543 people had died in Hungary of coronavirus-related causes and 310,448 had received at least a first dose of a vaccine.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป